Spencer R. Berthelsen, Director at IONIS PHARMACEUTICALS INC (IONS), sold 15,000 shares at $58.76 ($881K) on 2020-06-23, disclosed to the SEC on 2020-06-25.
Open-market sale of $881k IONS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IONS | SELL | 2024-06-20 | $645K | — | Filing → |
| IONS | SELL | 2021-06-25 | $566K | — | Filing → |
| IONS | SELL | 2019-06-26 | $1.9M | — | Filing → |